Negotiated reimbursement rates for D3356 across 39 states, sourced from CMS Transparency in Coverage data. 385 rate records.
D3356 represents the interim medication phase of pulpal regeneration. This procedure is typically performed after the initial visit and involves placing a medicated dressing to promote healing and prepare for the final treatment. Clinical indications include the need for temporary management of the pulp before definitive treatment. Documentation must detail the materials used, the rationale for interim treatment, and any patient responses. The average reimbursement for D3356 is around $130, but payor policies can vary, with some requiring specific documentation or limiting coverage based on the treatment plan.
Reimbursement rates for D3356 vary significantly by state, payor, and provider network. The national average negotiated rate is $130. Data sourced from CMS Transparency in Coverage machine-readable files, updated monthly.
36+ more states available with Pro ↓